Delaware | 001-15063 | 33-0618093 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| the term of the credit facility was extended for 90 days so that the new maturity date is May 27, 2009; | ||
| the tangible net worth covenant was modified to reduce the required tangible net worth for the months ending February 28, 2009, March 31, 2009 and April 30, 2009; and | ||
| SVB waived the Companys noncompliance with the tangible net worth covenant for the months ended December 31, 2008 and January 31, 2009. |
10.1
|
Limited Waiver and Amendment to Loan Documents, dated as of February 26, 2009, by and between Endocare, Inc. and Silicon Valley Bank. |
2
ENDOCARE, INC. |
||||
February 27, 2009 | By: | /s/ Michael R. Rodriguez | ||
Michael R. Rodriguez | ||||
Senior Vice President, Finance and Chief Financial Officer |
3